Table 1.
Baseline demographic and procedural characteristics.
| Items | Patients, n = 109 |
|---|---|
| Age (years) | 59.9 ± 10.2 |
| Male | 78 (71.6) |
| BMI (kg/m2) | 25.8 ± 2.8 |
| Hypertension | 78 (71.6) |
| Hyperlipidemia | 92 (84.4) |
| Diabetes | 58 (53.2) |
| Current smoker | 49 (45.0) |
| Family history of CAD | 26 (23.9) |
| Prior MI | 24 (22.0) |
| Prior stroke | 13 (11.9) |
| Prior PCI | 24 (22.0) |
| Prior CABG | 3 (2.8) |
| Acute coronary syndrome | 40 (36.7) |
| Multivessel CAD | 103 (94.5) |
| SYNTAX score | 21.7 ± 9.1 |
| LVEF (%) | 60.2 ± 8.0 |
| NT‐pro BNP (pg/mL) | 316.0 ± 501.0 |
| LDL‐C (mmol/L) | 2.2 ± 0.8 |
| Items | Lesions, n = 114 |
|---|---|
| Target vessel | |
| Left anterior descending | 47 (41.2) |
| Left circumflex | 36 (31.6) |
| Right coronary artery | 31 (27.2) |
| Location of lesion in treated vessel | |
| Proximal involved | 49 (43.0) |
| Mid/distal | 65 (57.0) |
| Balloon predilation | 114 (100.0) |
| Intracoronary imaging | |
| IVUS/OCT | 16 (14.0) |
| Hybrid strategy | |
| DES proximal with DCB distal | 92 (80.7) |
| DCB proximal with DES distal | 22 (19.3) |
| Device characteristics | |
| Number of DES per lesion | 1.5 ± 0.7 |
| Number of DCB per lesion | 1.1 ± 0.3 |
| DES length per lesion (mm) | 36.4 ± 19.3 |
| DCB length per lesion | 25.3 ± 10.3 |
| DES diameter per lesion | 2.7 ± 0.4 |
| DCB diameter per lesion | 2.4 ± 0.4 |
| TIMI flow grade | |
| Preprocedural TIMI flow grade 3 | 74 (64.9) |
| Postprocedural TIMI flow grade 3 | 114 (100.0) |
| Dissection postprocedural | 31 (27.2) |
Note: Values are expressed as mean ± SD or n (%).
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; CAD, coronary artery disease; DCB, drug‐coated balloon; DES, drug‐eluting stent; IVU, intravascular ultrasound; LDL‐C, low‐density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NT‐pro BNP, N‐terminal pro‐B‐type natriuretic peptide; OCT, optical coherence tomography; PCI, percutaneous coronary intervention; SYNTAX, synergy between percutaneous coronary intervention with taxus and cardiac surgery; TIMI, thrombolysis in myocardial infarction.